Clinical Trial Update: EPO-4-Rhesus Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update for an intervention related to fetal erythroblastosis and Rh disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroblastosis Fetal
• Erythroblastosis Fetalis
• Rh Disease

Snippet

Sponsor: Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research | Conditions: Erythroblastosis, Fetal, Erythroblastosis Fetalis, Rh Disease | Phase 2, Phase 3 | Status: UNKNOWN